Given that obesity and hypertension frequently coexist and together substantially increase cardiovascular and kidney risk, these findings support obesity treatment as an important component of blood pressure management and cardiovascular risk reduction, said lead researcher Marcel Muskiet, MD, PhD, an internist, endocrinologist, and vascular medicine specialist in the Department of Medicine at Leiden University Medical Center (LUMC) in the Netherlands
Analysis of 10,478 cancer genomes identifies candidate driver genes and opportunities for precision oncology
This reduction in metabolic heat production could potentially manifest as feeling colder than usual, especially in cooler environments
Accessing Weight Loss Medicines Safely Through UK Healthcare NICE-approved options including semaglutide (Wegovy) and tirzepatide (Zepbound) are available through NHS specialist weight management services or CQC- and GPhC-regulated private providers following a clinical consultation
For more information, please visit Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended
